Structure Therapeutics Faces Challenges with Weight-Loss Treatments
Structure Therapeutics is preparing to launch its weight-loss pill while confronting growing risks from unregulated compounded copycat drugs.
FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti
FDA warns of severe gut inflammation linked to Carvykti, a cancer therapy for multiple myeloma, but maintains its benefits outweigh…
GLP-1 Medications Transform Health and Household Budgets
GLP-1 drugs are revolutionizing weight loss—and personal finance. As health improves, Americans are rethinking budgets, spending, and long-term goals.
Drug Tied to Fatal Crashes and Risks of Weight-Loss Pills
Drug-related crashes and unsafe weight-loss pills are fueling a public health crisis, prompting experts to call for education, regulation, and…
GLP-1 Medications Like Ozempic May Affect Medical Scan Results
GLP-1 drugs like Ozempic may alter PET and CT scan readings, leading to potential misinterpretations and unnecessary procedures, researchers warn.
Dr. Andrew Weil Advocates for Integrative Medicine’s Role in Health Reform
Dr. Andrew Weil urges reform of the U.S. healthcare system, promoting integrative, prevention-focused care over costly, profit-driven disease management.
AstraZeneca Boosts Virginia Investment to $4.5 Billion for Drug Production
AstraZeneca expands its Virginia site to $4.5B, adding 3,600 jobs and advanced AI manufacturing for cancer and obesity drug production.
Nursing Homes’ Use of Painkillers and Antidepressants Raises Risks
Researchers warn that tramadol-antidepressant combinations heighten seizure risk in elderly patients, spotlighting over-medication in nursing homes.
FDA to Decide on Biohaven’s Ataxia Treatment in November
As the FDA weighs Biohaven’s SCA drug approval, patients and investors await a pivotal decision that could reshape rare disease…
Study: Medications Alter Gut Health Long After Use
Researchers find that most common drugs may cause lasting gut microbiome changes, highlighting the need for mindful medication and diet…
Sam’s Club Offers Affordable Ozempic, Wegovy for Weight Loss
Sam’s Club launches $499 pricing for Ozempic and Wegovy, expanding access to weight-loss meds and same-day delivery for refrigerated prescriptions.
Annual COVID Vaccines Essential for Severe Disease Protection
A new study reveals COVID boosters cut deaths by 64% and hospitalizations by 39%, offering protection across all age groups…
Covid Booster Shots: Are They Necessary for Younger Adults?
A VA study shows Covid vaccines reduce deaths by 64%, proving especially vital for those over 65 while offering modest…
AlphaMedix™ Excels in Phase 2 Study for GEP-NETs
AlphaMedix™ achieved major success in a phase 2 GEP-NET cancer trial, marking a breakthrough in targeted alpha therapy for advanced…
Study Questions Tramadol’s Effectiveness for Chronic Pain Relief
A new study reveals tramadol provides limited relief and higher risks, challenging its role as a safe opioid for managing…
More Americans Seek Unregulated GLP-1 Drugs Amid Shortages
FDA warns of growing risks from gray-market GLP-1 drugs as unregulated Ozempic and Wegovy alternatives raise safety and counterfeit concerns.
AstraZeneca Partners with Algen for Immunology Drug Discovery
AstraZeneca partners with Algen Biotech in a $555M AI and CRISPR deal to accelerate immunology drug discovery using Algen’s advanced…
Skye Bioscience’s Weight Loss Drug Underwhelms in Phase 2 Trial
Skye Bioscience shares sank 60% as its drug nimacimab missed weight-loss goals, though combo data with semaglutide hinted at potential…
AstraZeneca and Daiichi Sankyo Achieve Milestone in Cancer Study
AstraZeneca and Daiichi Sankyo’s Datroway achieved major success in a late-stage trial, offering new hope for patients with triple-negative breast…
Navigating Coffee’s Impact on Prescription Medications
Caffeine can impact how certain medications work. Discover safe timing tips to enjoy coffee without compromising your treatment’s effectiveness.
White House Launches ‘TrumpRX’ Drug Site, Pfizer Cuts Prices
President Trump introduces TrumpRX, a direct-to-consumer platform aimed at lowering prescription drug costs and improving medication access nationwide.
GLP-1 Drugs May Lower Cancer Risk for Women, Study Shows
GLP-1 drugs show promise in lowering cancer risks for women, while also improving obesity, fertility, and overall health outcomes.